AuctuCel is Live!
AuctuCel was founded to fix a problem every cell culture scientist knows: media that don’t work. Born as a spin-off from A*STAR’s Bioprocessing Technology Institute, we combine bioprocess expertise with computational tools to rethink media development.
The company was founded by Dr Zach Pang and Dr Fhu Chee Wai, who experienced the pain of suboptimal media firsthand — from Zach’s PhD at Imperial College London to Chee Wai’s work at the Cancer Science Institute of Singapore and in industry. Their shared frustration became a mission: to take the guesswork out of culture media and help researchers grow with confidence.
AuctuCel was featured in A*STAR newsroom and Genetic Engineering and Biotechnology News.
A new spinoff company is about to launch a computer model that aims to accelerate process development by speeding up the optimization of cell culture media. AuctuCel, which plans to open for business on June 1, will offer a mechanistic model that requires less client data to work than those based on artificial intelligence (AI), according to Zach Pang, PhD, group leader at the A*STAR Bioprocessing Technology Institute in Singapore.
Pang, who helped develop the model and introduced it at Bioprocessing Summit Europe in March, said, “Our key message is that you no longer have to perform laborious, time-consuming, manual optimization for culture media. Our new computational approach gives you an option that’s much faster and cheaper, helping accelerate your entire development timeline.”